The first stop for professional medicines advice

Omnipaque: informing intrathecal risk assessment

Published Last updated See all updates
Topics: Aseptic servicesIntrathecal medicinesIohexolRadiology

Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Contents
  1. Licensed for intrathecal use
    1. Omnipaque
    2. Iohexol
  2. No information available
  3. Update history

Licensed for intrathecal use

Products licensed for intrathecal use are the first line option and should be used wherever suitable.

Omnipaque

Strength

140mg I/mL in 50mL, 75mL, 100mL, 200mL bottles
240mg I/mL in 50mL, 75mL, 100mL, 200mL bottles
300mg I/mL in 50mL, 75mL, 100mL, 200mL bottles
350mg I/mL in 50mL, 75mL, 100mL, 200mL bottles

Iohexol

Strength

300mg I/mL in 50mL,100mL vials
350mg I/mL in 50mL,100mL vials

No information available

Products with very little or no information are rarely used for intrathecal administration.

There are currently no known additional omnipaque products.

Update history

  1. Title and URL shortened.
  1. Links updated
  1. Published

Print this page